BioRestorative Therapies
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-09-30 |
|---|---|---|---|
Revenue | $89 | $35 | $30 |
Gross Profit | 34 | -7 | -11 |
EBITDA | -2,421 | -4,066 | -3,104 |
EBIT | -2,468 | -4,109 | -3,146 |
Net Income | -4,028 | -2,223 | -83 |
Net Change In Cash | 89 | 35 | 30 |
Free Cash Flow | -1,900 | -2,317 | -1,189 |
Cash | 2,252 | 1,157 | 2,436 |
Basic Shares | 8,121 | 6,671 | 4,570 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $145 | $119 | $46 | $77 |
Gross Profit | -19 | -160 | -159 | 77 |
EBITDA | -15,055 | -18,992 | -42,398 | -3,288 |
EBIT | -15,220 | -19,113 | -42,604 | -3,440 |
Net Income | -10,417 | -18,015 | -29,938 | -12,254 |
Net Change In Cash | 145 | 119 | 46 | 77 |
Cost of Revenue | 3,562 | |||
Free Cash Flow | -6,601 | -6,310 | -3,360 | -1,964 |
Cash | 884 | 1,676 | 21,026 | 3,064 |
Basic Shares | 4,218 | 3,617 | 1,187 | 394 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.50 |
2024-03-31 | -$0.33 |
2023-12-31 | -$0.57 |
2023-09-30 | -$0.65 |
